In December 2024, Novo Nordisk announced that the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings was completed.

4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.

After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal ...

CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has appointed Amy Hay as Chief Business Officer and ...

Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new facilities, strategically positioned across key global markets ...

Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

Affinia Therapeutics, a gene therapy company with a pipeline of adeno-associated virus (AAV) gene therapies for devastating ...

In this webinar, Wayne Woodard, Chief Executive Officer of Argonaut Manufacturing Services, and Katie Edgar, Chief Business Officer of KBI Biopharma discuss the challenges unique to organizations ...

Earnings reflect R&D investments in 2024 including the acquisition of Kate Therapeutics, Mariana Oncology, IFM Due, MorphoSys AG, Calypso Biotech BV, and SanReno Therapeutics. Additionally, as the ...

With Veeva RIM, Servier has a solution that enables quick adaptation to evolving EU regulatory demands. Veeva is partnering ...

LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample ...